PRESS RELEASE published on 07/31/2025 at 07:00, 1 year ago Medacta Group SA reports continued above-market revenue growth of 19.8% in constant currency in H1 2025 and upgrades its FY 2025 and mid-term guidance Medacta Group SA reports 19.8% revenue growth in H1 2025, upgrades FY 2025 and mid-term guidance. Enhanced performance across all geographic markets and business lines Revenue Growth Business Performance Medacta Group SA Mid-term Outlook FY 2025 Guidance
BRIEF published on 05/07/2025 at 14:53, 1 year 2 months ago Medacta's AGM Approves All Board Proposals Shareholder Approval Dividend Distribution Board Re-election AGM 2025 Medacta Group
BRIEF published on 05/07/2025 at 14:53, 1 year 2 months ago L'assemblée générale annuelle de Medacta approuve toutes les propositions du conseil d'administration Approbation Des Actionnaires Réélection Du Conseil D'administration Distribution De Dividendes Groupe Medacta Assemblée Générale Annuelle 2025
PRESS RELEASE published on 05/07/2025 at 14:48, 1 year 2 months ago Medacta announces the results of today's Annual General Meeting Medacta Group SA announces successful outcomes of Annual General Meeting with approval of all proposals and distribution of CHF 13.7 million to shareholders Annual General Meeting Shareholders Medacta Group SA Distribution Approval
BRIEF published on 04/08/2025 at 10:05, 1 year 3 months ago Medacta Announces 2025 AGM Details Shareholders Dividends Re-election Proxy Voting Medacta AGM 2025
BRIEF published on 04/08/2025 at 10:05, 1 year 3 months ago Medacta annonce les détails de son assemblée générale annuelle 2025 Actionnaires Dividendes Vote Par Procuration Réélection Assemblée Générale Annuelle De Medacta 2025
PRESS RELEASE published on 04/08/2025 at 10:00, 1 year 3 months ago Medacta publishes 2025 Annual General Meeting invitation Medacta Group SA publishes 2025 Annual General Meeting invitation with proposed motions and details on date, time, and location Board Of Directors Shareholders Medacta Group SA AGM Invitation 2025 Annual General Meeting
BRIEF published on 03/25/2025 at 07:05, 1 year 4 months ago Medacta Group SA Reports Strong 2024 Results Revenue Increase Product Innovation EBITDA Margin Financial Growth 2024 Results
BRIEF published on 03/25/2025 at 07:05, 1 year 4 months ago Medacta Group SA annonce de solides résultats pour 2024 Croissance Financière Innovation Produit Marge D'EBITDA Résultats 2024 Augmentation Des Revenus
PRESS RELEASE published on 03/25/2025 at 07:00, 1 year 4 months ago Medacta Group SA: Medacta Group SA reports an excellent performance in 2024 with an adjusted EBITDA margin1 in constant currency of 28.0% Medacta Group SA reports excellent 2024 performance with 28.0% adjusted EBITDA margin. Revenue up 16.2% in constant currency. Board proposes CHF 0.69 per share distribution. Outlook targets 13-15% revenue growth & 27% EBITDA margin for 2025 Revenue Growth Adjusted EBITDA Margin Medacta Group SA 2024 Performance 2025 Outlook
Published on 08/05/2026 at 14:00, 47 minutes ago Lobe Sciences Announces Results of Annual General and Special Meeting of Shareholders
Published on 08/05/2026 at 13:30, 1 hour 17 minutes ago Nextech3D.ai Signs Strategic Partnership with F2B Services to Drive AI Software Adoption, Expand LED Display Opportunities and Accelerate Event Technology Growth
Published on 08/05/2026 at 13:30, 1 hour 17 minutes ago International Battery Metals Announces First Quarter Fiscal 2027 Financial Results Conference Call and Webcast
Published on 08/05/2026 at 13:00, 1 hour 47 minutes ago Global Education Communities Corp. Announces Executive Appointments and Leadership Updates
Published on 08/05/2026 at 13:00, 1 hour 47 minutes ago Galway Metals Reports Broad Gold Intercepts from Southwest Deposit, Including 2.6 g/t Over 48.0 Metres
Published on 08/05/2026 at 14:35, 12 minutes ago Utility Global Names Robert Lane Chief Financial Officer to Drive Commercialization at Scale
Published on 08/05/2026 at 14:30, 16 minutes ago Edison issues report on Templeton Emerging Markets Investment Trust (TEM)
Published on 08/05/2026 at 14:00, 46 minutes ago EUROPLASMA: Information relative au nombre total de droits de vote et d’actions composant le capital au 31 juillet 2026
Published on 08/05/2026 at 13:00, 1 hour 47 minutes ago Nebius appoints Lindsey Irvine as Chief Marketing Officer
Published on 08/05/2026 at 14:16, 30 minutes ago LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/07/2026
Published on 08/05/2026 at 13:52, 54 minutes ago Disclosure of Share Capital and Voting Rights as of July 31, 2026
Published on 08/05/2026 at 13:52, 54 minutes ago Déclaration du nombre d’actions et droits de vote au 31 juillet 2026
Published on 08/05/2026 at 13:33, 1 hour 14 minutes ago Actualisation du document d'enregistrement universel 2025